ABVX peer analysis
Abivax (ABVX) against its competitors: price, today's move, 1-year return and market value side by side.
ABVX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.90 | 8.03% | 59.73% | $570.34M |
| ANAB AnaptysBio | $45.80 | 0.48% | 26.61% | $1.42B |
| ANNX Annexon | $4.20 | 4.87% | 33.06% | – |
| AVTX Avalo Therapeutics | $7.05 | 6.33% | -58.12% | – |
| IMMX Immix Biopharma | $7.99 | 10.97% | 136.07% | – |
| IVA Inventiva | $3.83 | 5.51% | -10.49% | – |
| NRIX Nurix Therapeutics | $15.07 | 1.55% | 19.15% | – |
| RCUS Arcus Biosciences | $18.28 | 3.34% | -10.43% | $2.46B |
| SNDX Syndax Pharmaceuticals | $9.70 | 3.52% | -37.42% | $940.80M |
| SYRE Spyre Therapeutics | $103.00 | 6.64% | 322.71% | – |
| ABVX Abivax | $85.75 | 1.87% | -15.67% | $7.83B |
- ABVX's peers: ACRS (Aclaris Therapeutics), ANAB (AnaptysBio), ANNX (Annexon), AVTX (Avalo Therapeutics), IMMX (Immix Biopharma), IVA (Inventiva), NRIX (Nurix Therapeutics), RCUS (Arcus Biosciences).
Updated 2026-11-07 11:55 UTC